Our EA policy will apply to those DMG patients who exhausted standard of care and can't find appropriate trials to participate. We encourage a patient's provider (pediatric neuro-oncologist) to reach out to us so that we can discuss the case with the provider before an EA decision can be made based on the clinical data we collected so far and the information from each patient.